Cargando…
Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954815/ https://www.ncbi.nlm.nih.gov/pubmed/29692396 http://dx.doi.org/10.4103/jpgm.JPGM_353_17 |
| _version_ | 1783323593762930688 |
|---|---|
| author | Sharma, V |
| author_facet | Sharma, V |
| author_sort | Sharma, V |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5954815 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59548152018-06-01 Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible Sharma, V J Postgrad Med Editorial Commentary Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5954815/ /pubmed/29692396 http://dx.doi.org/10.4103/jpgm.JPGM_353_17 Text en Copyright: © 2018 Journal of Postgraduate Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Editorial Commentary Sharma, V Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible |
| title | Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible |
| title_full | Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible |
| title_fullStr | Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible |
| title_full_unstemmed | Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible |
| title_short | Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible |
| title_sort | pharmaco-invasive strategy: an attractive alternative for management of st-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954815/ https://www.ncbi.nlm.nih.gov/pubmed/29692396 http://dx.doi.org/10.4103/jpgm.JPGM_353_17 |
| work_keys_str_mv | AT sharmav pharmacoinvasivestrategyanattractivealternativeformanagementofstelevationmyocardialinfarctionwhentimelyprimarypercutaneouscoronaryinterventionisnotfeasible |